GRANIX Drug Profile

Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Summary for Tradename: GRANIX

Patents:	0
Applicants:	1
BLAs:	1
Suppliers: see list	1
Recent Clinical Trials:	See clinical trials for GRANIX

Recent Clinical Trials for GRANIX

Identify potential brand extensions & biosimilar entrants

Sponsor	Phase
Northwestern University	Phase 2
Northwestern University	Phase 2/Phase 3
Sidney Kimmel Cancer Center at Thomas Jefferson University	Phase 2

See all GRANIX clinical trials

Pharmacology for GRANIX

Ingredient-type	Granulocyte Colony-Stimulating Factor Granulocyte-Macrophage Colony-Stimulating Factor
Physiological Effect	Increased Myeloid Cell Production

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.